AI-Assisted Relaxation and Breathing Training in Postmenopausal Women

NCT ID: NCT07302750

Last Updated: 2025-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2027-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effectiveness of relaxation and breathing training delivered by a physiotherapist and by an artificial intelligence-assisted system in postmenopausal women with non-specific chronic musculoskeletal pain. Menopause and the postmenopausal period are associated with decreased estrogen levels, structural and functional changes in the musculoskeletal system, increased pain prevalence, reduced muscle function, and impaired quality of life. Relaxation techniques, breathing-focused exercises, and mind-body practices have been shown to reduce pain, improve psychological well-being, and enhance sleep quality. With the growing use of digital health technologies, AI-supported relaxation training may offer personalized guidance, easy accessibility, and sustainable home-based practice, although its effectiveness in postmenopausal women has not yet been demonstrated.

In this three-arm randomized controlled trial, participants will be assigned to physiotherapist-led relaxation and breathing training, AI-assisted relaxation and breathing training, or a control group. Interventions will last eight weeks and include sessions three days per week, each approximately 30 minutes. The physiotherapist-guided group will perform sessions face-to-face, while the AI-assisted group will complete prerecorded relaxation and breathing exercises created with AI-generated scripts and voice recordings. The control group will continue daily routines without structured training during the study period.

Assessments will be conducted at baseline and at the end of eight weeks. Outcome measures will include pain severity, pressure pain threshold, musculoskeletal symptoms, menopause-specific quality of life, psychological status, sleep quality, dyspnea, and participant satisfaction. The study aims to compare the effects of physiotherapist-led and AI-assisted training modalities on pain, musculoskeletal health, sleep, psychological well-being, and quality of life. Findings are expected to contribute to the development of accessible and cost-effective interventions that support symptom management and improve the daily functioning of postmenopausal women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Menopause is a natural biological process defined by the 12 months following a woman's last menstrual cycle. It typically occurs between the ages of 40 and 50, with an average age of onset of around 51. The menopause process is divided into three main phases: perimenopause, menopause, and postmenopause. Perimenopause encompasses the few years preceding menopause, when menstrual cycles become irregular and vasomotor symptoms such as hot flashes and night sweats first appear. The menopausal period is defined as the absence of menstrual bleeding for 12 consecutive months, during which time typical menopausal symptoms become apparent. Postmenopause is the period that lasts for the remainder of a woman's life after menopause. During postmenopause, the decline in estrogen levels causes structural and functional changes in the musculoskeletal system, negatively affecting the integrity of bones, muscles, tendons, and ligaments. The risk of developing sarcopenia and osteoporosis increases during this period. Estrogen contributes to energy metabolism by regulating mitochondrial function in muscle cells; estrogen deficiency results in a decrease in mitochondrial numbers and impaired muscle metabolism. Furthermore, decreased estrogen can increase apoptosis in skeletal muscle, disrupt muscle protein balance, and negatively affect muscle strength. During this period, the prevalence of musculoskeletal pain increases with age, from premenopause to perimenopause and postmenopause. The prevalence of musculoskeletal pain in perimenopausal women has been reported to be approximately 71%; it has also been found that postmenopausal women have a significantly increased risk of experiencing moderate to severe pain compared to premenopausal women. In the literature, methods such as progressive muscle relaxation, breathing-focused awareness exercises and meditation-based relaxation techniques have been shown to reduce pain severity, reduce stress levels and improve quality of life in individuals experiencing chronic pain. These techniques facilitate control of pain perception by reducing muscle tension, improving breathing patterns, and balancing autonomic nervous system responses. For chronic musculoskeletal pain seen in menopausal and postmenopausal women, relaxation training stands out as an effective complementary physiotherapy-based method and significantly contributes to maintaining women's quality of life. Furthermore, chronic pain and menopausal symptoms are closely related to sleep disorders. Studies have shown that relaxation techniques and body-mind-based practices improve sleep quality. It has been reported that relaxation techniques can have positive effects not only on psychological well-being but also on musculoskeletal health. In particular, they have been reported to increase ease of movement and contribute to functional capacity by reducing muscle tension. While the effectiveness of traditional relaxation methods is well known, it is also thought that digital health technologies developed in recent years may offer new opportunities for physiotherapy practices. It has been reported that AI-based systems can be integrated into relaxation and mindfulness applications, providing personalized feedback to guide exercises and enabling sustainable practice in the home environment. Web-based interventions have been found effective in improving the health and quality of life of individuals across various diseases, health behaviors, and psychological conditions due to their advantages such as easy access, low cost, and anonymity. However, despite these strengths, the current status of AI-supported interventions, particularly those related to menopause, remains unclear. However, AI technologies hold the potential to provide personalized care, symptom prediction, and digital support in the management of menopausal symptoms. Furthermore, the effectiveness of AI-based relaxation training applications has not yet been demonstrated. There is a need for long-term, sustainable approaches to the management of chronic pain during menopause and postmenopause that will enhance the potential health benefits. In this context, our study aims to contribute to the literature and clinical practice by comparing the effectiveness of physiotherapist-assisted and AI-assisted relaxation training in postmenopausal women.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postmenopausal Period Postmenopausal Women

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

postmenopausal artificial intelligence pain management quality of life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Physiotherapist-Guided Relaxation and Breathing Training

Participants will receive individual face-to-face relaxation and breathing training supervised by a physiotherapist.

Group Type ACTIVE_COMPARATOR

Physiotherapist-Guided Relaxation and Breathing Training

Intervention Type OTHER

Participants will perform the sessions individually and face-to-face under the supervision of a physiotherapist. Relaxation positions and breathing exercises will be guided and monitored by the physiotherapist. The training will be conducted three days a week for eight weeks, with each session lasting approximately 30 minutes.

Artificial Intelligence-Assisted Relaxation and Breathing Training

Participants will follow an AI-generated relaxation and breathing training program.

Group Type EXPERIMENTAL

Artificial Intelligence-Assisted Relaxation and Breathing Training

Intervention Type OTHER

In this group, a 30-minute relaxation and breathing training script will be created by the researchers based on instructional prompts provided to the artificial intelligence system. The generated script will be reviewed and finalized by the researchers and then converted into an audio file using an AI-based voice generation program. Participants will listen to these audio recordings asynchronously via smartphone or tablet, three days a week for eight weeks, with each session lasting approximately 30 minutes. They will also be asked to keep a daily practice log.

Control Group

Participants receive general information about relaxation and breathing exercises but do not participate in a structured program during the eight-week study period.

Group Type SHAM_COMPARATOR

Control Group - No Structured Training Program

Intervention Type OTHER

Participants will be informed about relaxation and breathing exercises. After the initial assessments, they will be asked to continue their daily routines and not to participate in any structured exercise training program for eight weeks. After the intervention period, participants in the control group will be invited to join one of the training groups if they wish.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physiotherapist-Guided Relaxation and Breathing Training

Participants will perform the sessions individually and face-to-face under the supervision of a physiotherapist. Relaxation positions and breathing exercises will be guided and monitored by the physiotherapist. The training will be conducted three days a week for eight weeks, with each session lasting approximately 30 minutes.

Intervention Type OTHER

Artificial Intelligence-Assisted Relaxation and Breathing Training

In this group, a 30-minute relaxation and breathing training script will be created by the researchers based on instructional prompts provided to the artificial intelligence system. The generated script will be reviewed and finalized by the researchers and then converted into an audio file using an AI-based voice generation program. Participants will listen to these audio recordings asynchronously via smartphone or tablet, three days a week for eight weeks, with each session lasting approximately 30 minutes. They will also be asked to keep a daily practice log.

Intervention Type OTHER

Control Group - No Structured Training Program

Participants will be informed about relaxation and breathing exercises. After the initial assessments, they will be asked to continue their daily routines and not to participate in any structured exercise training program for eight weeks. After the intervention period, participants in the control group will be invited to join one of the training groups if they wish.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women aged 45 to 65 years
* Being in natural menopause (no menstrual bleeding for at least 12 months)
* Having non-specific chronic musculoskeletal pain for at least 3 months (reporting a pain intensity of at least 4 cm on the VAS)
* Using only standard analgesic medications for pain management
* Being literate
* Owning a smartphone or tablet, having the ability to listen to audio recordings, and having adequate skills to participate in online sessions
* Being willing to participate in the study and providing written informed consent

Exclusion Criteria

* Surgical or medication-induced menopause
* Regular use of opioid analgesics, anticonvulsants, antidepressants, or similar medications
* Uncontrolled advanced cardiovascular, oncological, metabolic, rheumatologic, or neurological diseases
* Body Mass Index (BMI) of 40 kg/m² or higher
* History of major surgery or severe trauma within the past 3 months
Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baskent University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Neslihan Duruturk

Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neslihan Durutürk, Prof. Dr.

Role: STUDY_DIRECTOR

Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation

Aslıcan Çağlar, Asst. Prof.

Role: PRINCIPAL_INVESTIGATOR

Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation

Şeyma Mutlu Kayaarslan, MSc.

Role: PRINCIPAL_INVESTIGATOR

Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation

Hilal Yazici İlhan, MSc.

Role: PRINCIPAL_INVESTIGATOR

Başkent University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baskent University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Neslihan Durutürk, Prof. Dr.

Role: CONTACT

Phone: +90312 246 66 66

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996 Jul;24(3):161-75. doi: 10.1016/s0378-5122(96)82006-8.

Reference Type BACKGROUND
PMID: 8844630 (View on PubMed)

Alaca N, Safran EE, Karamanlargil AI, Timucin E. Translation and cross-cultural adaptation of the extended version of the Nordic musculoskeletal questionnaire into Turkish. J Musculoskelet Neuronal Interact. 2019 Dec 1;19(4):472-481.

Reference Type BACKGROUND
PMID: 31789298 (View on PubMed)

Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56. doi: 10.1016/0304-3959(83)90126-4.

Reference Type BACKGROUND
PMID: 6226917 (View on PubMed)

Garg R, Munshi A. Revolutionizing Menopause Management: Harnessing the Potential of Artificial Intelligence. J Midlife Health. 2024 Apr-Jun;15(2):53-54. doi: 10.4103/jmh.jmh_104_24. Epub 2024 Jul 5. No abstract available.

Reference Type BACKGROUND
PMID: 39145262 (View on PubMed)

Ağargün et al. Turkish PSQI validity. Turkish Journal of Psychiatry. 1996;7:107-115.

Reference Type BACKGROUND

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

Reference Type BACKGROUND
PMID: 2748771 (View on PubMed)

Cotes JE. Medical Research Council Questionnaire on Respiratory Symptoms (1986). Lancet. 1987 Oct 31;2(8566):1028. doi: 10.1016/s0140-6736(87)92593-1. No abstract available.

Reference Type BACKGROUND
PMID: 2889937 (View on PubMed)

Aydemir O. Turkish validation of HADS. Turkish Journal of Psychiatry. 1997;8:187-280.

Reference Type BACKGROUND

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

Reference Type BACKGROUND
PMID: 6880820 (View on PubMed)

Turhan E, Inandi T. Assessment of reliability and validity of the Menopause-Specific Quality of Life Questionnaire in a Turkish population. HealthMED. 2011;5:111.

Reference Type BACKGROUND

Rughani G, Nilsen TIL, Wood K, Mair FS, Hartvigsen J, Mork PJ, Nicholl BI. The selfBACK artificial intelligence-based smartphone app can improve low back pain outcome even in patients with high levels of depression or stress. Eur J Pain. 2023 May;27(5):568-579. doi: 10.1002/ejp.2080. Epub 2023 Jan 27.

Reference Type BACKGROUND
PMID: 36680381 (View on PubMed)

Vambheim SM, Kyllo TM, Hegland S, Bystad M. Relaxation techniques as an intervention for chronic pain: A systematic review of randomized controlled trials. Heliyon. 2021 Aug 20;7(8):e07837. doi: 10.1016/j.heliyon.2021.e07837. eCollection 2021 Aug.

Reference Type BACKGROUND
PMID: 34485731 (View on PubMed)

Doorley J, Greenberg J, Stauder M, Vranceanu AM. The role of mindfulness and relaxation in improved sleep quality following a mind-body and activity program for chronic pain. Mindfulness (N Y). 2021 Nov;12(11):2672-2680. doi: 10.1007/s12671-021-01729-y. Epub 2021 Sep 1.

Reference Type BACKGROUND
PMID: 34900019 (View on PubMed)

Ong JC, Manber R, Segal Z, Xia Y, Shapiro S, Wyatt JK. A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep. 2014 Sep 1;37(9):1553-63. doi: 10.5665/sleep.4010.

Reference Type BACKGROUND
PMID: 25142566 (View on PubMed)

Dunford E, DClinPsy MT. Relaxation and Mindfulness in Pain: A Review. Rev Pain. 2010 Mar;4(1):18-22. doi: 10.1177/204946371000400105.

Reference Type BACKGROUND
PMID: 26524978 (View on PubMed)

Saensak S, Vutyavanich T, Somboonporn W, Srisurapanont M. Relaxation for perimenopausal and postmenopausal symptoms. Cochrane Database Syst Rev. 2014 Jul 20;2014(7):CD008582. doi: 10.1002/14651858.CD008582.pub2.

Reference Type BACKGROUND
PMID: 25039019 (View on PubMed)

Amin SM, El-Gazar HE, Zoromba MA, El-Sayed MM, Awad AGE, Atta MHR. Mindfulness for Menopausal Women: Enhancing Quality of Life and Psychological Well-Being Through a Randomized Controlled Intervention. J Nurs Scholarsh. 2025 Jul;57(4):563-575. doi: 10.1111/jnu.70003. Epub 2025 Feb 24.

Reference Type BACKGROUND
PMID: 39992004 (View on PubMed)

Xu H, Liu J, Li P, Liang Y. Effects of mind-body exercise on perimenopausal and postmenopausal women: a systematic review and meta-analysis. Menopause. 2024 May 1;31(5):457-467. doi: 10.1097/GME.0000000000002336.

Reference Type BACKGROUND
PMID: 38669625 (View on PubMed)

Lu CB, Liu PF, Zhou YS, Meng FC, Qiao TY, Yang XJ, Li XY, Xue Q, Xu H, Liu Y, Han Y, Zhang Y. Musculoskeletal Pain during the Menopausal Transition: A Systematic Review and Meta-Analysis. Neural Plast. 2020 Nov 25;2020:8842110. doi: 10.1155/2020/8842110. eCollection 2020.

Reference Type BACKGROUND
PMID: 33299396 (View on PubMed)

Collins BC, Laakkonen EK, Lowe DA. Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength. Bone. 2019 Jun;123:137-144. doi: 10.1016/j.bone.2019.03.033. Epub 2019 Mar 28.

Reference Type BACKGROUND
PMID: 30930293 (View on PubMed)

Zhang C, Feng X, Zhang X, Chen Y, Kong J, Lou Y. Research progress on the correlation between estrogen and estrogen receptor on postmenopausal sarcopenia. Front Endocrinol (Lausanne). 2024 Nov 21;15:1494972. doi: 10.3389/fendo.2024.1494972. eCollection 2024.

Reference Type BACKGROUND
PMID: 39640884 (View on PubMed)

Ambikairajah A, Walsh E, Cherbuin N. A review of menopause nomenclature. Reprod Health. 2022 Jan 31;19(1):29. doi: 10.1186/s12978-022-01336-7.

Reference Type BACKGROUND
PMID: 35101087 (View on PubMed)

Santoro N. Perimenopause: From Research to Practice. J Womens Health (Larchmt). 2016 Apr;25(4):332-9. doi: 10.1089/jwh.2015.5556. Epub 2015 Dec 10.

Reference Type BACKGROUND
PMID: 26653408 (View on PubMed)

Davis SR, Baber RJ. Treating menopause - MHT and beyond. Nat Rev Endocrinol. 2022 Aug;18(8):490-502. doi: 10.1038/s41574-022-00685-4. Epub 2022 May 27.

Reference Type BACKGROUND
PMID: 35624141 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KA25/405

Identifier Type: -

Identifier Source: org_study_id